Exercise tolerance, fatigue, mental health, and employment status at 5 and 12 months following COVID-19 illness in a physically trained population.

cardiopulmonary exercise exercise tolerance long COVID post-COVID-19 syndrome recovery

Journal

Journal of applied physiology (Bethesda, Md. : 1985)
ISSN: 1522-1601
Titre abrégé: J Appl Physiol (1985)
Pays: United States
ID NLM: 8502536

Informations de publication

Date de publication:
01 03 2023
Historique:
pubmed: 10 2 2023
medline: 9 3 2023
entrez: 9 2 2023
Statut: ppublish

Résumé

Failure to recover following severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) may have a profound impact on individuals who participate in high-intensity/volume exercise as part of their occupation/recreation. The aim of this study was to describe the longitudinal cardiopulmonary exercise function, fatigue, and mental health status of military-trained individuals (up to 12-mo postinfection) who feel recovered, and those with persistent symptoms from two acute disease severity groups (hospitalized and community-managed), compared with an age-, sex-, and job role-matched control. Eighty-eight participants underwent cardiopulmonary functional tests at baseline (5 mo following acute illness) and 12 mo; 25 hospitalized with persistent symptoms (hospitalized-symptomatic), 6 hospitalized and recovered (hospitalized-recovered); 28 community-managed with persistent symptoms (community-symptomatic); 12 community-managed, now recovered (community-recovered), and 17 controls. Cardiopulmonary exercise function and mental health status were comparable between the 5 and 12-mo follow-up. At 12 mo, symptoms of fatigue (48% and 46%) and shortness of breath (SoB; 52% and 43%) remain high in hospitalized-symptomatic and community-symptomatic groups, respectively. At 12 mo, COVID-19-exposed participants had a reduced capacity for work at anaerobic threshold and at peak exercise levels of deconditioning persist, with many individuals struggling to return to strenuous activity. The prevalence considered "fully fit" at 12 mo was lowest in symptomatic groups (hospitalized-symptomatic, 4%; hospitalized-recovered, 50%; community-symptomatic, 18%; community-recovered, 82%; control, 82%) and 49% of COVID-19-exposed participants remained medically nondeployable within the British Armed Forces. For hospitalized and symptomatic individuals, cardiopulmonary exercise profiles are consistent with impaired metabolic efficiency and deconditioning at 12 mo postacute illness. The long-term deployability status of COVID-19-exposed military personnel is uncertain.

Identifiants

pubmed: 36759161
doi: 10.1152/japplphysiol.00370.2022
pmc: PMC10010915
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

622-637

Références

Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Chest. 2022 Jan;161(1):54-63
pubmed: 34389297
Am J Clin Oncol. 1982 Dec;5(6):649-55
pubmed: 7165009
Eur Respir J. 2021 Aug 26;58(2):
pubmed: 34244323
Thorax. 2021 Apr;76(4):396-398
pubmed: 33172844
N Engl J Med. 2005 May 12;352(19):1951-8
pubmed: 15888695
Clin Microbiol Infect. 2021 Feb;27(2):258-263
pubmed: 33031948
Clin Microbiol Infect. 2021 Jan;27(1):89-95
pubmed: 32979574
COPD. 2005 Mar;2(1):125-9
pubmed: 17136972
Circulation. 2001 Oct 2;104(14):1694-740
pubmed: 11581152
Heart Rhythm. 2022 Apr;19(4):613-620
pubmed: 34896622
BMJ Mil Health. 2022 Aug;168(4):314-319
pubmed: 33087537
JAMA Cardiol. 2020 Nov 01;5(11):1265-1273
pubmed: 32730619
Med Sci Sports Exerc. 2000 Sep;32(9 Suppl):S498-504
pubmed: 10993420
PLoS One. 2020 Nov 9;15(11):e0240784
pubmed: 33166287
BMC Public Health. 2017 Dec 13;17(1):952
pubmed: 29237442
J Physiol. 1997 Jun 15;501 ( Pt 3):677-86
pubmed: 9218227
Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7
pubmed: 12091180
Respir Med. 2022 Oct;202:106968
pubmed: 36081267
PM R. 2011 Jun;3(6):527-32
pubmed: 21665165
J Trauma Stress. 2015 Dec;28(6):489-98
pubmed: 26606250
Med Sci Sports Exerc. 1982;14(5):377-81
pubmed: 7154893
Laryngoscope Investig Otolaryngol. 2020 Dec 02;5(6):1019-1028
pubmed: 33365393
Eur Respir J. 2021 Aug 26;58(2):
pubmed: 34210791
Lancet Respir Med. 2022 Aug;10(8):761-775
pubmed: 35472304
Med Sci Sports Exerc. 1994 Sep;26(9):1078-81
pubmed: 7808239
N Engl J Med. 2021 Aug 12;385(7):577-579
pubmed: 34192429
JAMA. 2020 Aug 11;324(6):603-605
pubmed: 32644129
J Clin Med. 2021 Jun 11;10(12):
pubmed: 34208271
Clin Microbiol Infect. 2022 May;28(5):657-666
pubmed: 35124265
EClinicalMedicine. 2021 Jan 07;31:100683
pubmed: 33490928
Nat Med. 2021 Jul;27(7):1129-1130
pubmed: 34140704
Ann Intern Med. 2021 Apr;174(4):576-578
pubmed: 33175566
Thorax. 2022 Mar;77(3):300-303
pubmed: 34588274
Thorax. 2022 Jul;77(7):717-720
pubmed: 35354642
Int J Soc Psychiatry. 2021 Feb;67(1):54-63
pubmed: 32605422
J Infect. 2020 Dec;81(6):e4-e6
pubmed: 32853602
Br J Sports Med. 2020 Aug;54(16):949-959
pubmed: 32475821
Acta Otolaryngol. 2021 Mar;141(3):299-302
pubmed: 33307905
Radiology. 2021 Apr;299(1):E177-E186
pubmed: 33497317
J Psychosom Res. 2003 Apr;54(4):345-52
pubmed: 12670612
Nat Med. 2020 Jul;26(7):1037-1040
pubmed: 32393804
BMJ Mil Health. 2021 Feb 5;:
pubmed: 33547188
Respir Res. 2020 Oct 21;21(1):276
pubmed: 33087116
Mayo Clin Proc. 2021 Jan;96(1):32-39
pubmed: 33413833
Eur Respir J. 2021 Aug 26;58(2):
pubmed: 33926969
Health Policy. 1990 Dec;16(3):199-208
pubmed: 10109801
Eur Respir J. 2023 Feb 2;61(2):
pubmed: 36137587
BMJ Mil Health. 2021 May 26;:
pubmed: 34039689
PLoS One. 2022 Jun 10;17(6):e0267392
pubmed: 35687603
Sports Med Open. 2023 Feb 2;9(1):7
pubmed: 36729302
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
EClinicalMedicine. 2021 Nov;41:101159
pubmed: 34693230
Lung. 2021 Jun;199(3):249-253
pubmed: 33993321
J Appl Physiol (1985). 2022 Jun 1;132(6):1525-1535
pubmed: 35608204
J Clin Med. 2021 Jun 30;10(13):
pubmed: 34209085
Am J Respir Crit Care Med. 2019 Oct 15;200(8):e70-e88
pubmed: 31613151
Exp Ther Med. 2021 Mar;21(3):244
pubmed: 33603852
Med Sci Sports Exerc. 1984 Jun;16(3):278-82
pubmed: 6748926
MMWR Morb Mortal Wkly Rep. 2020 Jul 31;69(30):993-998
pubmed: 32730238

Auteurs

Peter Ladlow (P)

Academic Department of Military Rehabilitation (ADMR), Defence Medical Rehabilitation Centre (DMRC), Loughborough, United Kingdom.
Department for Health, University of Bath, Bath, United Kingdom.

David A Holdsworth (DA)

Academic Department of Military Medicine, Birmingham, United Kingdom.
Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.

Oliver O'Sullivan (O)

Academic Department of Military Rehabilitation (ADMR), Defence Medical Rehabilitation Centre (DMRC), Loughborough, United Kingdom.
Headquarters Army Medical Directorate (HQ AMD), Camberley, United Kingdom.

Robert M Barker-Davies (RM)

Academic Department of Military Rehabilitation (ADMR), Defence Medical Rehabilitation Centre (DMRC), Loughborough, United Kingdom.
School of Sport, Exercise and Health Sciences, Loughborough University, Loughborough, United Kingdom.

Andrew Houston (A)

Academic Department of Military Rehabilitation (ADMR), Defence Medical Rehabilitation Centre (DMRC), Loughborough, United Kingdom.

Rebecca Chamley (R)

Academic Department of Military Medicine, Birmingham, United Kingdom.
Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.

Kasha Rogers-Smith (K)

Academic Department of Military Rehabilitation (ADMR), Defence Medical Rehabilitation Centre (DMRC), Loughborough, United Kingdom.

Victoria Kinkaid (V)

Academic Department of Military Rehabilitation (ADMR), Defence Medical Rehabilitation Centre (DMRC), Loughborough, United Kingdom.

Adam Kedzierski (A)

Academic Department of Military Rehabilitation (ADMR), Defence Medical Rehabilitation Centre (DMRC), Loughborough, United Kingdom.

Jon Naylor (J)

Royal Centre for Defence Medicine, Birmingham, United Kingdom.

Joseph Mulae (J)

Royal Centre for Defence Medicine, Birmingham, United Kingdom.

Mark Cranley (M)

Defence Medical Rehabilitation Centre (DMRC), Loughborough, United Kingdom.

Edward D Nicol (ED)

Academic Department of Military Medicine, Birmingham, United Kingdom.
Royal Brompton Hospital, London, United Kingdom.
School of Biomedical Engineering and Imaging Sciences, Kings College London, London, United Kingdom.

Alexander N Bennett (AN)

Academic Department of Military Rehabilitation (ADMR), Defence Medical Rehabilitation Centre (DMRC), Loughborough, United Kingdom.
National Heart and Lung Institute, Imperial College London, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH